Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine

We previously reported that topical imiquimod can improve the immunogenicity of the influenza vaccine. This study investigated another FDA-approved drug, miltefosine (MTF), as a vaccine adjuvant. Mice immunized with an influenza vaccine with or without MTF adjuvant were challenged by a lethal dose o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccines (Basel)
Main Authors: Lu, Lu, Fong, Carol Ho-Yan, Zhang, Anna Jinxia, Wu, Wai-Lan, Li, Iris Can, Lee, Andrew Chak-Yiu, Dissanayake, Thrimendra Kaushika, Chen, Linlei, Hung, Ivan Fan-Ngai, Chan, Kwok-Hung, Chu, Hin, Kok, Kin-Hang, Yuen, Kwok-Yung, To, Kelvin Kai-Wang
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768360/
https://ncbi.nlm.nih.gov/pubmed/33322574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040754
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares